Phase I trial of TAK‐385 in hormone treatment‐naïve Japanese patients with nonmetastatic prostate cancer.

MLA

Suzuki, Hiroyoshi, et al. “Phase I Trial of TAK‐385 in Hormone Treatment‐naïve Japanese Patients with Nonmetastatic Prostate Cancer.” Cancer Medicine, vol. 8, no. 13, Oct. 2019, pp. 5891–902. EBSCOhost, https://doi.org/10.1002/cam4.2442.

APA

Suzuki, H., Uemura, H., Mizokami, A., Hayashi, N., Miyoshi, Y., Nagamori, S., Enomoto, Y., Akaza, H., Asato, T., Kitagawa, T., & Suzuki, K. (2019). Phase I trial of TAK‐385 in hormone treatment‐naïve Japanese patients with nonmetastatic prostate cancer. Cancer Medicine, 8(13), 5891–5902. https://doi.org/10.1002/cam4.2442

Chicago

Suzuki, Hiroyoshi, Hiroji Uemura, Atsushi Mizokami, Narihiko Hayashi, Yasuhide Miyoshi, Satoshi Nagamori, Yutaka Enomoto, et al. 2019. “Phase I Trial of TAK‐385 in Hormone Treatment‐naïve Japanese Patients with Nonmetastatic Prostate Cancer.” Cancer Medicine 8 (13): 5891–5902. doi:10.1002/cam4.2442.